Highlights Avicanna Inc.

Equities

AVCN

CA05368K1003

Market Closed - Toronto S.E. Other stock markets 01:19:59 21/06/2024 am IST			5-day change	1st Jan Change
0.275 ^CAD	0.00%		+7.84%	-21.43%

19/06	US Patent and Trademark Office Issues Patent For Avicanna's SEDDS Technology	MT
19/06	Avicanna Brief: Announcing USPTO Issuance of Patent SEDDS Technology	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

US Patent and Trademark Office Issues Patent For Avicanna's SEDDS Technology	19/06	MT
Avicanna Brief: Announcing USPTO Issuance of Patent SEDDS Technology	19/06	MT
Avicanna Announces United States Patent and Trademark Office Issuance of Patent SEDDS Technology	19/06	CI
Avicanna Up 4.5% as it Books Record Q1 Revenue, First Adjusted EBITDA Positive Quarter in Company History	14/05	MT
Avicanna Books Record Q1 Revenue, First Adjusted Ebitda Positive Quarter in Company History	14/05	MT
Avicanna Brief: Record Q1 revenue of $6.45 million representing a year-over-year increase of 451% compared to Q1 2023	14/05	MT
Avicanna Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
Avicanna Announced Results of Study in Patients with Epidermolysis Bullosa	13/05	MT
Avicanna Brief: Announcing Results of Study in Patients with Epidermolysis Bullosa	13/05	MT
Avicanna Inc. Announces Results of Study in Patients with Epidermolysis Bullosa	13/05	CI
Avicanna Raises About $2.1 Million in Non-brokered Private Placement	19/04	MT
Avicanna Inc. Announces Completion of Topical Gel Observational Real-World Evidence Study	10/04	CI
Avicanna's Q4 Loss Narrows, Revenue Grows	02/04	MT
Avicanna Brief: Reporting $16.8 Million in 2023 Revenue, representing an increase of 314% from 2022	02/04	MT
Avicanna Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
Avicanna Announced Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	27/03	MT
Avicanna Brief: Announcing Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	27/03	MT
Avicanna Inc Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	27/03	CI
ThreeD Capital Inc. Announces New YouTube Channel	26/03	MT
Avicanna Reports New Research Collaboration With Multi-national European-based Pharmaceutical Firm; Down 5.6%	16/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Avicanna Inc.

Equities

AVCN

CA05368K1003

Highlights

Filters